Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Udgivet den 18-08-2017  |  kl. 17:37  |  

Valby, Denmark, 2017-08-18 17:37 CEST (GLOBE NEWSWIRE) -- Valby, Denmark, 18 August 2017 - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.

1. Details of the person discharging managerial responsibilities /
person closely associated
a) Name Anders Gersel Pedersen
2. Reason for the notification
a) Position/status Executive Vice President, Research & Development
b) Initial notification/Amendment Initial notification
3. Details of  the issuer,  emission  allowance  market participant,
auction platform, auctioneer or auction monitor
a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instrument

Identification code

Warrant
 
 
 
DK 0010287234
b) Nature of the transaction Other transaction (exercise of warrants in accordance with long-term incentive programme)
c) Price(s) and volume(s) Price(s) Volume(s)
    156.16 160,000
d) Aggregated information
- Aggregated volume
- Price
 
e) Date of the transaction 2017-08-18
f) Place of the transaction Outside a trading venue (the shares will be listed on NASDAQ Copenhagen XCSE)

 

  
 

1. Details of the person discharging managerial responsibilities /
person closely associated
a) Name Anders Götzsche
2. Reason for the notification
a) Position/status Executive Vice President & Chief Financial Officer
b) Initial notification/Amendment Initial notification
3. Details of  the issuer,  emission  allowance  market participant,
auction platform, auctioneer or auction monitor
a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instrument

Identification code

Warrant
 
 
 
DK 0010287234
b) Nature of the transaction Other transaction (exercise of warrants in accordance with long-term incentive programme)
c) Price(s) and volume(s) Price(s) Volume(s)
    156.16  280,796
d) Aggregated information
- Aggregated volume
- Price
 
e) Date of the transaction 2017-08-18
f) Place of the transaction Outside a trading venue (the shares will be listed on NASDAQ Copenhagen XCSE)

 

Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  • spouse or cohabitant
  • dependent children
  • legal entities in which the executive has a controlling influence.

 

Lundbeck contacts

Investors: Media:
   
Palle Holm Olesen Mads Kronborg
Vice President,  Investor Relations Senior Director, Corp. Communication
palo@lundbeck.com mavk@lundbeck.com
+45 30 83 24 26 +45 36 43 40 00

 

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are Alzheimer's disease, depression, Parkinson's disease and schizophrenia.

Our approximately 5,000 employees in 55 countries are engaged in the entire value chain throughout research, development, manufacturing, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have production facilities in Denmark, France and Italy. Lundbeck generated revenue of DKK 15.6 billion in 2016 (EUR 2.1 billion; USD 2.2 billion).

For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck.

Vedhæftede filer:

UK PDF.pdf

Udgivet af: NPinvestordk

Seneste nyheder

08:22 Carlsberg sænkes til "hold" hos Jyske Bank efter stærk årsstart
08:18 Aktier/tendens: Rød dag i vente efter voldsom amerikansk nedtur - Novo og Genmab i fokus
08:03 Norsk storbank og Genmab: Fokus fremtid efter partners beslutning om Hexabody
07:53 Genmab får skåret kursmålet til 2300 kr. fra 2500 kr. af SEB efter kursklø
07:46 Tysklands De Grønne ser mulighed for finanspolitisk aftale inden ugen er omme
07:25 Trump kommer Elon Musk til undsætning: Vil købe en "splinterny Tesla"
07:17 Obligationer/tendens: Renter kan dykke efter ny Trump-panik og før jobtal
07:05 Danske Bank forventer blodrøde markeder efter største aktieudsalg i over to år
06:40 Asien: Frygt for at Trumps toldregime ender i recession dominerer
06:34 Genmabs kursmålet sænkes 10 pct. af Truist
06:34 Genmab får skåret kursmålet hos Deutsche Bank efter Hexabody-melding
06:34 Rockwool får højere kursmål hos JPMorgan
06:34 Genmabs topchef: Har flere opkøbsmål på radaren
06:32 Asien: Frygt for at Trumps toldregime ender i recession dominerer
06:32 Valuta: Aggressiv amerikansk told frygtes at lægge USA's økonomiske vækst i graven
06:32 USA/T-bond: Recessionsfrygt pressede markedsrenter ned
06:32 USA/lukning: Største nedtur siden december - Trump smider aktier under bussen
06:30 Kalender med link - tirsdag den 11. marts
17:55 Europa/lukning: Novo-nedtur og tvivl om tysk investeringspakke sendte indeks i knæ
17:07 Mandagens aktier: Novo-data rykkede C25 i minus - Mærsk gik frem på houthi-trussel